Immunocore Holdings (IMCR) Return on Capital Employed (2024 - 2026)

Immunocore Holdings has disclosed Return on Capital Employed across 3 years of filings, most recently posting 4.15% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 4.15%, up 132.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.15% (up 132.0% YoY), and the FY2025 annual result was 5.73%, up 619.0% from the prior year.
• Return on Capital Employed came in at 4.15% for Q1 2026 at Immunocore Holdings, up from 5.41% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 4.15% in Q1 2026 to a low of 11.16% in Q1 2024.
• The 3-year median for Return on Capital Employed is 5.47% (2025), against an average of 6.93%.
• Across the five-year window, Return on Capital Employed surged 569 bps in 2025 and soared 132 bps in 2026, its largest moves.
• Immunocore Holdings' Return on Capital Employed stood at 8.44% in 2024, then surged by 36 bps to 5.41% in 2025, then increased by 23 bps to 4.15% in 2026.
• The last three Return on Capital Employed figures came in at 4.15% (Q1 2026), 5.41% (Q4 2025), and 4.89% (Q3 2025), per Business Quant data.